The prevention of contrast-induced nephropathy by minimising the contrast agent “confers significant economical benefit”
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2009 |
---|---|
Erschienen: |
2009 |
Enthalten in: |
Zur Gesamtaufnahme - volume:588 |
---|---|
Enthalten in: |
PharmacoEconomics & outcomes news - 588(2009), 1 vom: Okt., Seite 10-10 |
Sprache: |
Englisch |
---|
Links: |
Volltext [lizenzpflichtig] |
---|
BKL: | |
---|---|
Themen: |
Chronic Kidney Disease |
doi: |
10.2165/00151234-200905880-00026 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
SPR033535353 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | SPR033535353 | ||
003 | DE-627 | ||
005 | 20230519092553.0 | ||
007 | cr uuu---uuuuu | ||
008 | 201007s2009 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.2165/00151234-200905880-00026 |2 doi | |
035 | |a (DE-627)SPR033535353 | ||
035 | |a (SPR)00151234-200905880-00026-e | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | 4 | |a 070 |a 610 |q ASE |
084 | |a 44.40 |2 bkl | ||
245 | 1 | 4 | |a The prevention of contrast-induced nephropathy by minimising the contrast agent “confers significant economical benefit” |
264 | 1 | |c 2009 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
650 | 4 | |a Public Health |7 (dpeaa)DE-He213 | |
650 | 4 | |a Health Outcome |7 (dpeaa)DE-He213 | |
650 | 4 | |a Chronic Kidney Disease |7 (dpeaa)DE-He213 | |
650 | 4 | |a Retrospective Study |7 (dpeaa)DE-He213 | |
650 | 4 | |a Kidney Disease |7 (dpeaa)DE-He213 | |
773 | 0 | 8 | |i Enthalten in |t PharmacoEconomics & outcomes news |d [Cham] : Springer Nature Switzerland, 1996 |g 588(2009), 1 vom: Okt., Seite 10-10 |w (DE-627)SPR033353808 |w (DE-600)2159696-7 |x 1179-2043 |7 nnns |
773 | 1 | 8 | |g volume:588 |g year:2009 |g number:1 |g month:10 |g pages:10-10 |
856 | 4 | 0 | |u https://dx.doi.org/10.2165/00151234-200905880-00026 |z lizenzpflichtig |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_SPRINGER | ||
912 | |a SSG-OLC-PHA | ||
912 | |a SSG-OPC-PHA | ||
912 | |a SSG-OPC-ASE | ||
936 | b | k | |a 44.40 |q ASE |
951 | |a AR | ||
952 | |d 588 |j 2009 |e 1 |c 10 |h 10-10 |